Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Daniel Grossman BS

Daniel Grossman BS

Doctoral Student, Medical/Clinical Psychology Doctoral Program, University of Alabama at Birmingham, Birmingham, Alabama

Dan Grossman, BS, is a third-year Medical/Clinical Psychology PhD student under Dr. Peter Hendricks at the University of Alabama at Birmingham. His current research focuses on the epidemiology of psychedelic substance use, and psychedelic-assisted therapy for various indications. He hopes to enhance the safety and ethics of clinical trial and treatment protocol design in this evolving field. As a clinician in training, he is also committed to exploring mind-body interventions, trauma-informed care, and "third wave" therapy.

Recent Contributions to PracticeUpdate:

  1. Single-Dose Psilocybin Treatment for Major Depressive Disorder